Survodutide is an investigational long-acting, glucagon/GLP-1 receptor targeting obesity by increasing energy expenditure and reducing food intake and MASH.
Description
Additional information
| Weight |
N/A |
|---|---|
| mg |
6mg , 12mg |
Test Report
